Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China · Delayed Price · Currency is CNY 24.68
-0.12 (-0.48%)
Sep 16, 2026, 3:04 PM CST
SHE:002317 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,223 | 2,523 | 2,467 | 2,611 | 2,676 | 2,429 |
Revenue Growth | -7.46% | 2.24% | -5.48% | -2.45% | 10.17% | 28.13% |
Gross Profit Gross Profit Growth | 1,220 | 1,411 | 1,332 | 1,529 | 1,735 | 1,615 |
Operating Income Operating Income Growth | 198.5 | 285.75 | 206.95 | 346.21 | 380.45 | 368.16 |
Net Income Net Income Growth | 199.28 | 275.75 | -299.16 | 263.27 | 322.05 | 277.63 |
Earnings Per Share EPS Growth | 0.24 | 0.33 | -0.36 | 0.32 | 0.40 | 0.35 |
EPS Growth | - | - | - | -20.00% | 14.29% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 2,121 | 2,405 | 2,342 | 2,483 | 2,554 | 2,341 |
Medicine Trade Medicine Trade Growth | 90.35 | 102.71 | 101.84 | 117.53 | 111.09 | 75.53 |
Unallocated Other Operating Income Unallocated Other Operating Income Growth | 11.82 | 15.49 | 23.35 | 10.39 | 10.72 | 12.74 |
Total Total Growth | 2,223 | 2,523 | 2,467 | 2,611 | 2,676 | 2,429 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,517 | 1,310 | 1,869 | 2,324 | 1,420 | 1,296 |
Total Debt Total Debt Growth | 123.78 | 326.3 | 305.43 | 724.6 | 902.17 | 516.98 |
Net Cash (Debt) Net Cash Growth | 1,393 | 984.14 | 1,564 | 1,600 | 517.93 | 779.3 |
Net Cash Growth | 52.00% | -37.06% | -2.24% | 208.85% | -33.54% | -14.76% |
Net Cash Per Share Net Cash Per Share Growth | 1.66 | 1.18 | 1.88 | 1.94 | 0.64 | 0.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 807.29 | 305.2 | 337.84 | 190.61 | 63.07 | 622.77 |
Capital Expenditures CapEx Growth | -326.28 | -316.17 | -228.26 | -363.06 | -267.96 | -213.76 |
Free Cash Flow Free Cash Flow Growth | 481.01 | -10.97 | 109.58 | -172.44 | -204.89 | 409 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 54.86% | 55.92% | 53.99% | 58.58% | 64.82% | 66.50% |
Operating Margin | 8.93% | 11.33% | 8.39% | 13.26% | 14.22% | 15.16% |
Pretax Margin | 9.19% | 11.76% | -13.61% | 10.87% | 13.76% | 12.74% |
Profit Margin | 8.96% | 10.93% | -12.12% | 10.08% | 12.03% | 11.43% |
FCF Margin | 21.63% | -0.43% | 4.44% | -6.61% | -7.66% | 16.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.200 | 0.200 | 0.200 | 0.200 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.81% | 1.06% | 1.69% | 1.29% | 0.78% | 1.76% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 103.67 | 58.50 | - | 51.69 | 67.76 | 34.73 |
Forward PE | 77.13 | 36.95 | 33.75 | 16.57 | 16.57 | 16.57 |
P/FCF Ratio | 43.61 | - | 93.80 | - | - | 23.57 |
PS Ratio | 9.43 | 6.40 | 4.17 | 5.21 | 8.15 | 3.97 |